Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea FDA Adds Teeth To Regs By Adding State Prosecutor To Safety Team

This article was originally published in PharmAsia News

Executive Summary

SEOUL - In an effort to increase compliance and give teeth to safety regulations, Korea FDA has begun to operate its version of U.S. FDA's Consumer Safety Inspector as it tries to counter illegal production and sales of what it calls "harmful" drugs, devices and food

You may also be interested in...



Korean Drug Regulators Raid Roche Korea, Search For Evidence On Tamiflu Stockpiling

SEOUL - An investigative team organized by the Korean FDA, and headed by a state prosecutor, raided the Seoul office of Roche on November 5 to search for and seize any documents that would confirm suspicions that Roche Korea might have helped some companies stockpile the antiviral drug Tamiflu

Korean Drug Regulators Raid Roche Korea, Search For Evidence On Tamiflu Stockpiling

SEOUL - An investigative team organized by the Korean FDA, and headed by a state prosecutor, raided the Seoul office of Roche on November 5 to search for and seize any documents that would confirm suspicions that Roche Korea might have helped some companies stockpile the antiviral drug Tamiflu

Korea Pharma Manufacturing Association Takes Steps To Snag Unethical Member Companies

SEOUL - Amid stepped-up government surveillance of the local pharma industry, the Korea Pharmaceutical Manufacturers Association is opening what it calls a "distribution irregularity reporting center," in an effort to stop illegal deals among drug companies, hospitals and pharmacies

Related Content

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel